Shares of GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report) were up 240.7% during trading on Thursday . The stock traded as high as $0.21 and last traded at $0.17. Approximately 209,259 shares were traded during trading, an increase of 1,089% from the average daily volume of 17,606 shares. The stock had previously closed at $0.05.
GeoVax Labs Stock Performance
The company’s 50 day moving average price is $0.05 and its 200 day moving average price is $0.04.
About GeoVax Labs
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Recommended Stories
- Five stocks we like better than GeoVax Labs
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- 3 Small Caps With Big Return Potential
- MarketBeat Week in Review – 6/24 – 6/28
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
